<!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''-->

<!--Is there a regimen missing from this list? Would you like to share a different dosage/schedule or an additional reference for a regimen? Have you noticed an error? Do you have an idea that will help the site grow to better meet your needs and the needs of many others? You are [[How_to_contribute|invited to contribute to the site]].-->

Unknown squamous cell carcinoma may also be referred to as carcinoma of unknown primary site, cancer of unknown primary (CUP), occult primary, or unknown primary carcinoma.

{| class="wikitable" style="float:right; margin-right: 5px;"
|-
|<div style="background-color: #fee0d1; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}" align="right"><font size="4"><b>{{#ask: [[-Has subobject::{{FULLPAGENAME}}]] |?Regimen |limit=10000|format=sum}} [[Tutorial#Regimens|regimens]] on this page</b></font></div>
<div style="background-color: #deebf6; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}"><font size="4"><b>{{#ask: [[-Has subobject::{{FULLPAGENAME}}]] |?Variant |limit=10000|format=sum}} [[Tutorial#Variants|variants]] on this page</b></font></div>
|}
{{TOC limit|limit=3}}

=Guidelines=
==[http://www.esmo.org/ ESMO]==
*[http://annonc.oxfordjournals.org/content/26/suppl_5/v133.full.pdf+html Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015)] [https://www.ncbi.nlm.nih.gov/pubmed/26314775 PubMed]

==[https://www.nccn.org/ NCCN]==
*[https://www.nccn.org/professionals/physician_gls/pdf/occult.pdf NCCN Guidelines - Occult Primary (Cancer of Unknown Primary (CUP)]

=All lines of therapy=
==DCF {{#subobject:3f05e4|Regimen=1}}==
{| class="wikitable" style="float:right; margin-left: 5px;"
|-
|[[#top|back to top]]
|}
DCF: '''<u>D</u>'''ocetaxel, '''<u>C</u>'''isplatin, '''<u>F</u>'''luorouracil
===Regimen {{#subobject:2ae092|Variant=1}}===
''Note: Various guidelines list this as a suitable regimen in this setting, but we are not aware of any specific protocols for this setting.''
====Chemotherapy====
*[[Docetaxel (Taxotere)]] 75 mg/m<sup>2</sup> IV once on day 1
*[[Cisplatin (Platinol)]] 75 mg/m<sup>2</sup> IV once on day 1
*[[Fluorouracil (5-FU)]] 750 mg/m<sup>2</sup>/day IV continuous infusion over 120 hours, started on day 1 (total dose per cycle: 3750 mg/m<sup>2</sup>)

====Supportive medications====
*1 liter normal saline before and after [[Cisplatin (Platinol)]] +/- mannitol, potassium chloride, magnesium sulfate
*[[Dexamethasone (Decadron)]] 8 mg PO once per day the day before, the day of, and day after chemotherapy
*[[Ciprofloxacin (Cipro)]] 1000 mg PO (reference did not specify, but assume 500 mg twice per day) on days 5 to 15

'''21-day cycle for 3 cycles'''
===References===
# None that we are aware of
==PCF {{#subobject:71face|Regimen=1}}==
{| class="wikitable" style="float:right; margin-left: 5px;"
|-
|[[#top|back to top]]
|}
PCF: '''<u>P</u>'''aclitaxel, '''<u>C</u>'''isplatin, '''<u>F</u>'''luorouracil
===Regimen {{#subobject:c82ab5|Variant=1}}===
''Note: Various guidelines list this as a suitable regimen in this setting, but we are not aware of any specific protocols for this setting.''
====Chemotherapy====
*[[Paclitaxel (Taxol)]] 175 mg/m<sup>2</sup> IV over 3 hours once on day 1
*[[Cisplatin (Platinol)]] 100 mg/m<sup>2</sup> IV once on day 2
*[[Fluorouracil (5-FU)]] 500 mg/m<sup>2</sup>/day IV continuous infusion over 120 hours, started on day 2 (total dose per cycle: 2500 mg/m<sup>2</sup>)

====Supportive medications====
*[[Dexamethasone (Decadron)]] 30 minutes before [[Paclitaxel (Taxol)]]
*[[Diphenhydramine (Benadryl)]] 30 minutes before [[Paclitaxel (Taxol)]]
*[[Cimetidine (Tagamet)]] or [[Ranitidine (Zantac)]] 30 minutes before [[Paclitaxel (Taxol)]] 

'''21-day cycle for 3 cycles'''
===References===
# None that we are aware of

[[Category:SCC of unknown primary regimens]]
[[Category:Site-agnostic regimens]]
